FDA-cleared profile

SmartTarget

SmartTarget, Ltd. · Ultrasound · FDA-cleared (510(k))

Authorized purpose: SmartTarget is an accessory for image-guided interventional and diagnostic prostate procedures that enhances two-dimensional transrectal ultrasound, reconstructs three-dimensional ultrasound, and displays multiplanar views, annotations, and instrument location for procedures such as biopsy, ablation, and brachytherapy.

Clinical role
Accessory software for prostate procedures that reconstructs digitized two-dimensional transrectal ultrasound into three-dimensional views and supports fusion or registration with previously created three-dimensional image sets.
Images and patients
Ultrasound · Prostate
Key limitation
Keep in mind: Use is limited to the labeled prostate and transrectal-ultrasound workflow. SmartTarget does not steer or control instruments and does not support transrectal instrument insertion; labeled positioning routes are transperineal, urethral, or external.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: SmartTarget is an accessory for image-guided interventional and diagnostic prostate procedures that enhances two-dimensional transrectal ultrasound, reconstructs three-dimensional ultrasound, and displays multiplanar views, annotations, and instrument location for procedures such as biopsy, ablation, and brachytherapy.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Prostate Input: Two-dimensional transrectal ultrasound, digitized transrectal-ultrasound video reconstructed to three dimensions, and previously created three-dimensional images such as MRI or CT stored as DICOM slices.
  • Who uses it?Intended users: Physicians performing image-guided interventional or diagnostic prostate procedures.
  • What does the software produce?Output: Two-dimensional and three-dimensional visualization, fusion or registration, multiplanar reconstruction, annotations, recorded instrument locations, and reports. The cleared configuration imports DICOM images but does not export DICOM objects.
  • What is its most important limitation?Key limitation: Use is limited to the labeled prostate and transrectal-ultrasound workflow. SmartTarget does not steer or control instruments and does not support transrectal instrument insertion; labeled positioning routes are transperineal, urethral, or external.

Clinical takeaway. Clinical role: SmartTarget is an accessory for image-guided interventional and diagnostic prostate procedures that enhances two-dimensional transrectal ultrasound, reconstructs three-dimensional ultrasound, and displays multiplanar views, annotations, and instrument location for procedures such as biopsy, ablation, and brachytherapy.

Evidence takeaway. Evidence from the reviewed source record: The K170250 FDA decision summary documents nonclinical phantom testing with a 2.0 mm image-alignment error and a 2.9 mm needle-tip placement error for the exact SmartTarget configuration. These bench results do not establish clinical outcomes or performance for unlabeled anatomy, instruments, or workflows.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
SmartTarget is an accessory for image-guided interventional and diagnostic prostate procedures that enhances two-dimensional transrectal ultrasound, reconstructs three-dimensional ultrasound, and displays multiplanar views, annotations, and instrument location for procedures such as biopsy, ablation, and brachytherapy.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Accessory software for prostate procedures that reconstructs digitized two-dimensional transrectal ultrasound into three-dimensional views and supports fusion or registration with previously created three-dimensional image sets.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Two-dimensional transrectal ultrasound, digitized transrectal-ultrasound video reconstructed to three dimensions, and previously created three-dimensional images such as MRI or CT stored as DICOM slices.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Two-dimensional and three-dimensional visualization, fusion or registration, multiplanar reconstruction, annotations, recorded instrument locations, and reports. The cleared configuration imports DICOM images but does not export DICOM objects.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Clinic and hospital settings.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Physicians performing image-guided interventional or diagnostic prostate procedures.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
Use is limited to the labeled prostate and transrectal-ultrasound workflow. SmartTarget does not steer or control instruments and does not support transrectal instrument insertion; labeled positioning routes are transperineal, urethral, or external.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
The K170250 FDA decision summary documents nonclinical phantom testing with a 2.0 mm image-alignment error and a 2.9 mm needle-tip placement error for the exact SmartTarget configuration. These bench results do not establish clinical outcomes or performance for unlabeled anatomy, instruments, or workflows.
  • Exact FDA submission
  • Checked 2026-09-04

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The K170250 FDA decision summary documents nonclinical phantom testing with a 2.0 mm image-alignment error and a 2.9 mm needle-tip placement error for the exact SmartTarget configuration. These bench results do not establish clinical outcomes or performance for unlabeled anatomy, instruments, or workflows.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No exact submission-linked sensitivity endpoint with a verified population, threshold, tested version, and source was promoted.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No exact submission-linked specificity endpoint with a verified population, threshold, tested version, and source was promoted.

Image alignment error

2 mm

  • EndpointImage registration alignment error in nonclinical phantom testing
  • PopulationProstate-procedure phantom
  • Tested versionSmartTarget configuration described in K170250

Needle-tip placement error

2.9 mm

  • EndpointNeedle-tip placement error in nonclinical phantom testing
  • PopulationProstate-procedure phantom
  • Tested versionSmartTarget configuration described in K170250

K170250 FDA evidence package for SmartTarget

  • DesignNonclinical phantom testing of image alignment and needle-tip placement in the exact SmartTarget configuration
  • PopulationProstate-procedure phantom data; no clinical patient cohort was reported for these two measurements
  • Scopeexact submission
  • Tested versionSmartTarget configuration described in K170250
  • IndependenceSponsor or vendor study

K170250

Manufacturer bench evidence submitted for the exact FDA decision. The reported errors are phantom measurements, not independent clinical validation or patient-outcome evidence.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
1 exact-submission FDA recall record matched K170250 in the 2026-09-02 openFDA snapshot. Confirm affected model, version, units, correction, and current manufacturer instructions locally. FDA recall Z-1243-2026 is Open, Classified for Focalyx Fusion. FDA reason: Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biopsy or cause treatment/therapy delays, so firm is recommending stop use until device is verified/validated with Windows 11. FDA action: On 12/23/2025, correction notices started being emailed to customers informing them of the following: You will be contacted to schedule installation of the new version. An IFU will be provided at time of installation. Complete and return the response form via email to corporate@focalyx.com If there are any questions, contact the firm at: focalyxtechnologies.com/contact, support@focalyxtechnologies.com, (888) 636 2259, (Sel. 3 Technical Support)
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-1243-2026

Open, Classified

2026-02-03

Native exact-submission identifier match from the openFDA candidate snapshot accessed 2026-09-04 with source snapshot date 2026-09-02. Source URL: https://api.fda.gov/device/recall.json?search=product_res_number.exact%3A%22Z-1243-2026%22&limit=1. This does not establish exact installed serial, lot, unit, or software-version applicability. The FDA record does not establish an AI-algorithm defect unless it says so.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Two-dimensional transrectal ultrasound, digitized transrectal-ultrasound video reconstructed to three dimensions, and previously created three-dimensional images such as MRI or CT stored as DICOM slices.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · K170250 FDA 510(k) decision summary

  2. Routing

    Source context, not route validation: The cleared software imports prior MRI or CT image sets as DICOM slices but does not export DICOM objects; local acceptance must verify the actual import, identity, registration, reporting, archive, and downtime workflow.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · K170250 FDA 510(k) decision summary

  3. AI processing

    Source context, not route validation: Windows PC-based software used with supported transrectal-ultrasound input and a third-party mechanical stepper device in clinic or hospital settings.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 · K170250 FDA 510(k) decision summary

  4. Returned objects

    Source context, not route validation: Two-dimensional and three-dimensional visualization, fusion or registration, multiplanar reconstruction, annotations, recorded instrument locations, and reports. The cleared configuration imports DICOM images but does not export DICOM objects.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · K170250 FDA 510(k) decision summary

  5. Viewer/worklist/report

    Unresolved route: Two-dimensional and three-dimensional visualization, fusion or registration, multiplanar reconstruction, annotations, recorded instrument locations, and reports. The cleared configuration imports DICOM images but does not export DICOM objects.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · K170250 FDA 510(k) decision summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Windows PC-based software used with supported transrectal-ultrasound input and a third-party mechanical stepper device in clinic or hospital settings.
  • Exact FDA submission
  • Checked 2026-09-04
Integration
The cleared software imports prior MRI or CT image sets as DICOM slices but does not export DICOM objects; local acceptance must verify the actual import, identity, registration, reporting, archive, and downtime workflow.
  • Exact FDA submission
  • Checked 2026-09-04
Training
Only qualified physicians, sonographers, and other appropriately trained ultrasound professionals should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K170250 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

Exact public integration details remain incomplete; establish and test the supported input, output, identity, routing, archive, report, and downtime contract locally.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the exact labeled population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Probe, mode, anatomy, population, acoustic window, workflow, and optional-feature limits vary by exact system and release.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. An exact-submission recall match exists; confirm affected model, version, units, correction, and completion status before acceptance.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K170250
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Prostate
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2017-06-07
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
12Source classes checked
3Screened PubMed leads
4Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 3 PubMed and 4 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 3 PubMed and 4 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 1 FDA recall candidate was manually reviewed: 1 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 1 postmarket candidate record; 1 has been reviewed (1 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating license or hardware basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed
  • Monitoring: Not publicly available - checked 2026-09-04 - Exact FDA submission

    The exact FDA decision and checked recall snapshot do not establish a complete local postmarket monitoring protocol. Track version, population, anatomy, protocol, input quality, edits, failures, repeats, downstream effects, downtime, incidents, recalls, and updates locally.

7 sources - 3 history items

Source ledger

  1. K170250 FDA 510(k) decision summary

    U.S. Food and Drug Administration - Accessed 2026-09-04

    Scope: purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, integration, deployment, evidenceSummary, evidenceMetrics

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-1243-2026: Focalyx Fusion

    U.S. Food and Drug Administration - Published 2026-02-03 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  7. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

Research history

  1. K170250 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29
FDA-cleared K260190

ARTHUR

ROPCA ApS

Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.

Modality
Ultrasound
Anatomy
Hand/Wrist
Decision
2026-06-18
FDA-cleared K260844

ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: ACUSON Sequoia, Select, Origin, and Origin ICE diagnostic ultrasound systems acquire and display the labeled fetal, abdominal, pediatric, neonatal, cephalic, small-part, obstetric, cardiac, transesophageal, intracardiac, vascular, and musculoskeletal examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; transesophageal and intracardiac applications
Decision
2026-06-16

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history